Event of Visual Impairment and Loss with Off-Label Administration of AVASTIN Injection

Authors

  • Yasmeen Fatima Department of Pharmacy, Jinnah University for Women, Karachi, Pakistan
  • Wasim Ahmad Department of Medical Affairs, Getz Pharma, Karachi, Pakistan

DOI:

https://doi.org/10.35787/jimdc.v13i2.1146

Abstract

In the middle of September 2023, frequent cases of vision loss and impairment of diabetic patients were reported in Lahore-Pakistan. Many diabetic patients lost their precious vision. with the progression of the cases, the DRAP (Drug Regulatory Authority of Pakistan) found that patients were administered an Avastin 100mg/4ml injection (an angiogenic drug used for treating colorectal and other metastatic carcinomas)2. Up to 65 cases were reported in the province of Punjab. 

Downloads

Published

29-07-2024

Issue

Vol. 13 No. 2 (2024): Apr-Jun 2024

Section

Letter to the Editor

License

Creative Commons License
This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.